SCHEMBL922407

SCHEMBL922407

Cc1ccc(S(=O)(=O)OCCOCCOS(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
CA1 P00915 3/20 0.49
CA9 Q16790 3/20 0.49
CA12 O43570 2/20 0.49
GAA P10253 2/20 0.46
STAT3 P40763 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
CA2 P00918 2/20 0.43
CA3 P07451 1/20 0.43
CA6 P23280 1/20 0.43
CA5A P35218 1/20 0.43
CA7 P43166 1/20 0.43
CA5B Q9Y2D0 1/20 0.43
VDR P11473 1/20 0.42
TLR9 Q9NR96 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18644929 1.00 ALDH1A1 (0.53) ALDH1A1CA1CA9CA12GAA
SCHEMBL18613994 1.00 ALDH1A1 (0.53) ALDH1A1CA1CA9CA12GAA
SCHEMBL12865316 1.00 ALDH1A1 (0.53) ALDH1A1CA1CA9CA12GAA
SCHEMBL4379133 1.00 ALDH1A1 (0.53) ALDH1A1CA1CA9CA12GAA
SCHEMBL1145153 1.00 ALDH1A1 (0.53) ALDH1A1CA1CA9CA12GAA
SCHEMBL881292 1.00 ALDH1A1 (0.53) ALDH1A1CA1CA9CA12GAA
SCHEMBL478342 1.00 ALDH1A1 (0.53) ALDH1A1CA1CA9CA12GAA
SCHEMBL241884 0.94 CA1 (0.52) ALDH1A1CA1CA9CA12GAA
SCHEMBL25398474 0.93 ALDH1A1 (0.47) ALDH1A1CA1CA9CA12GAA
SCHEMBL1218220 0.93 ALDH1A1 (0.47) ALDH1A1CA1CA9CA12GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 272 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119930514-A Isosteviol-based fluorescent probe and preparation method and application thereof 南京工业大学 2025-05-06 CN claimed
CN-119177050-B Infrared shielding coating and preparation method thereof 成都彩星化工有限公司 2025-01-28 CN claimed
CN-119177050-A Infrared shielding coating and preparation method thereof 成都彩星化工有限公司 2024-12-24 CN claimed
CN-118290412-A Glutamate dehydrogenase degradation agent and preparation method and application thereof 杭州汉菁生物科技有限公司 2024-07-05 CN claimed
CN-116178258-B N-methylaniline quinoline compound and synthetic method and application thereof 中国医学科学院北京协和医院 2023-11-21 CN claimed
CN-116178258-A N-methylaniline quinoline compound and synthetic method and application thereof 中国医学科学院北京协和医院 2023-05-30 CN claimed
US-12600730-B2 Substituted cyclopenta[c]pyrroles as ABHD6 antagonists ONO PHARMACEUTICAL CO., LTD. (JP) 2026-04-14 US disclosed
US-12600831-B2 Latex hyperbranched anion exchangers DIONEX CORPORATION (US) 2026-04-14 US disclosed
EP-3814356-B1 TRIAZOLOTRIAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS ZHEJIANG VIMGREEN PHARMACEUTICALS LTD (CN) 2026-03-11 EP disclosed
EP-4661984-A1 LATEX HYPERBRANCHED ANION EXCHANGERS Dionex Corporation (US) 2025-12-17 EP disclosed
US-12377152-B2 Compounds for degrading alpha-synuclein aggregates and uses thereof APRINOIA THERAPEUTICS LIMITED (CN) 2025-08-05 US disclosed
EP-3924349-B1 AMINO ACID DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES THE ROSKAMP INST (US) 2025-06-25 EP disclosed
CN-120092035-A Cationically curable composition 日产化学株式会社 2025-06-03 CN disclosed
EP-0742210-A1 2-MERCAPTOBENZIMIDAZOLE DERIVATIVE AND ANTIHYPERLIPEMIC OR ANTIARTERIOSCLEROTIC AGENT CONTAINING THE SAME FUJI PHOTO FILM CO., LTD. (JP) 1996-11-13 EP disclosed
US-5439511-A Composition containing polymer obtained by polymerizing unsaturated acid anhydride and another unsaturated compound, specified additive HITACHI CHEMICAL COMPANY, LTD. (JP) 1995-08-08 US disclosed
EP-0608132-A1 Coating varnish composition and antifouling coating composition HITACHI CHEMICAL CO., LTD. (JP) 1994-07-27 EP disclosed
US-5006129-A Dyeing textile material with pigment dyes: pre-treatment with quaternary ally ammonium salt polymer HOECHST AKTIENGESELLSCHAFT (DE) 1991-04-09 US disclosed
EP-0194751-A1 Dihydropyridine alkanol amines, process for their preparation and pharmaceutical compositions containing them IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-09-17 EP disclosed
US-4137080-A POLYFUNCTIONAL COUPLER AND DEVELOPER KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1979-01-30 US disclosed
US-3936429-A Reactive polymer FUJI PHOTO FILM CO., LTD. (JA) 1976-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12377152-B2 Compounds for degrading alpha-synuclein aggregates and uses thereof SNCA, PARK7, PRNP ALDH1A1 2065/4885CA1 3596/4885CA9 4039/4885
US-12600831-B2 Latex hyperbranched anion exchangers PLTP, SELP, LARP1 ALDH1A1 1544/4885CA1 1969/4885CA9 1409/4885
US-12600730-B2 Substituted cyclopenta[c]pyrroles as ABHD6 antagonists ABHD6, ABHD16A, HDHD5 ALDH1A1 548/4885CA1 3330/4885CA9 2854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.